• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：FGF1异常表达与mTOR-S6K1在结直肠癌中的关联

Corrigendum: The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer.

作者信息

Duan Tinghui, Zhou Diyuan, Yao Yizhou, Shao Xinyu

机构信息

Department of Medical Imaging, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.

Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

Front Oncol. 2021 Oct 25;11:792453. doi: 10.3389/fonc.2021.792453. eCollection 2021.

DOI:10.3389/fonc.2021.792453
PMID:34760712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8574045/
Abstract

[This corrects the article DOI: 10.3389/fonc.2021.706838.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fonc.2021.706838。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e10/8574045/a3a7ab7fe23b/fonc-11-792453-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e10/8574045/a3a7ab7fe23b/fonc-11-792453-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e10/8574045/a3a7ab7fe23b/fonc-11-792453-g007.jpg

相似文献

1
Corrigendum: The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer.勘误：FGF1异常表达与mTOR-S6K1在结直肠癌中的关联
Front Oncol. 2021 Oct 25;11:792453. doi: 10.3389/fonc.2021.792453. eCollection 2021.
2
The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer.FGF1异常表达与mTOR-S6K1在结直肠癌中的相关性
Front Oncol. 2021 Sep 6;11:706838. doi: 10.3389/fonc.2021.706838. eCollection 2021.
3
The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer.NLRP3与p-S6K1异常表达在结直肠癌中的关联。
Pathol Res Pract. 2020 Jan;216(1):152737. doi: 10.1016/j.prp.2019.152737. Epub 2019 Nov 11.
4
Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.勘误：EXOSC5作为一种新型预后标志物通过激活ERK和AKT通路促进结直肠癌增殖。
Front Oncol. 2021 Apr 9;11:670041. doi: 10.3389/fonc.2021.670041. eCollection 2021.
5
Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.勘误：抗表皮生长因子受体（EGFR）治疗期间转移性结直肠癌的纵向循环肿瘤DNA分析
Front Oncol. 2022 May 11;12:903586. doi: 10.3389/fonc.2022.903586. eCollection 2022.
6
Corrigendum: Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.勘误：脂肪酸代谢相关长链非编码RNA是预测结直肠癌患者总生存期的潜在生物标志物。
Front Oncol. 2022 Jan 5;11:831864. doi: 10.3389/fonc.2021.831864. eCollection 2021.
7
Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.勘误：小檗碱和原花青素低聚物通过调节PI3K-Akt信号通路在结直肠癌中发挥协同作用。
Front Oncol. 2022 Jun 29;12:952180. doi: 10.3389/fonc.2022.952180. eCollection 2022.
8
Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation.丁酸盐通过部分下调 SIRT1 使 mTOR/S6K1 信号失活来抑制结直肠癌细胞 HCT116 的增殖并诱导其凋亡。
Mol Med Rep. 2019 May;19(5):3941-3947. doi: 10.3892/mmr.2019.10002. Epub 2019 Mar 1.
9
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.勘误：差异表达分析揭示CLCA1是结直肠癌的一种预后和诊断生物标志物。
Front Oncol. 2020 Dec 18;10:634122. doi: 10.3389/fonc.2020.634122. eCollection 2020.
10
Corrigendum: Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer - from the body fluid to tissue level.勘误：用于结直肠癌诊断和预后的生物标志物（mRNA和非编码RNA）——从体液到组织水平
Front Oncol. 2024 Sep 13;14:1476176. doi: 10.3389/fonc.2024.1476176. eCollection 2024.

引用本文的文献

1
Aberrant expression of AKR1B1 indicates poor prognosis and promotes gastric cancer progression by regulating the AKT-mTOR pathway.AKR1B1的异常表达预示着预后不良，并通过调节AKT-mTOR信号通路促进胃癌进展。
Aging (Albany NY). 2023 Sep 24;15(18):9661-9675. doi: 10.18632/aging.205041.
2
TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process.TYRO3 通过增强上皮-间充质转化过程促进结直肠癌的肿瘤发生和耐药性。
Aging (Albany NY). 2023 Apr 14;15(8):3035-3051. doi: 10.18632/aging.204656.